Merck KGaA aims for 2016 earnings growth thanks to takeover

DARMSTADT, Germany, March 8 (Reuters) - German drugs and chemicals maker Merck KGaA raised the prospect of an increase of more than 10 percent in adjusted core earnings this year, expecting additional profit from the takeover of lab supplies maker Sigma-Aldrich to offset higher expenses on drug development.